Skip to main content

Incidence Rate of Diagnosed Vitiligo 22.6 per 100,000 Person-Years

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

MONDAY, July 24, 2023 -- Vitiligo diagnosis is more common in older adults and in Hispanic/Latino and Asian American patients, according to a study published online July 19 in JAMA Dermatology.

Nicole Mastacouris, from the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New Hyde Park, New York, and colleagues estimated the incidence and prevalence of diagnosed vitiligo across age, sex, and racial and ethnic subgroups in a cohort study and cross-sectional study including electronic health records for children, adolescents, and adults across four U.S. census regions.

The incidence analysis included 2,980,778 patients with vitiligo, and the prevalence analysis included 1,057,534 patients. The researchers found that the overall incidence rate of diagnosed vitiligo was 22.6 per 100,000 person-years (PY) after adjustment for age and sex, and prevalence was 0.16 percent. Patients aged 60 to 69 years had the highest sex-adjusted overall incidence rate (22.6 per 100,000 PY), and prevalence was highest among those aged 70 years or older (0.21 percent). Asian American, Hispanic/Latino, those reporting other or multiple races, Black, and White patients had age-adjusted incidence rates of 41.2, 37.3, 31.1, 29.6, and 18.7 per 100,000 PY, respectively. Age-adjusted prevalence was highest among Hispanic/Latino patients followed by Asian American, those reporting other or multiple races, Black, and White patients (0.29, 0.27, 0.24, 0.22, and 0.13 percent, respectively).

"These observations may support improving awareness of vitiligo disease burden in medical and public sectors, informing research agendas, improving enrollment of racial and ethnic minority populations in trials, and developing health policies," the authors write.

One author disclosed ties to the pharmaceutical industry and is co-copyright holder of the HS-IGA and HiSQOL instruments.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2023

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.